The Recombinant Proteins Market is projected to reach USD 3.2 Billion by 2028 from USD 2.2 Billion in 2023, at a CAGR of 7.2% during the forecast period. Growth in the recombinant proteins market can be attributed to factors such as rising incidence of chronic diseases, increasing demand for biologics and biosimilars due to patent expirations, increasing government support for R&D and...